90694 Federal Register / Vol. 89, No. 222 / Monday, November 18, 2024 / Notices 

5Ferguson Rytr Dissent at 1–2. 

6 Id. at 6–7. 

7 Id. at 2. 

8 Id. at 7. 

9 Id. at 5–6. 

10 Id. at 6. 

11 Id. at 7–9. 

12 Ibid. 

13FTC Policy Statement on Deception, 103 F.T.C. 

174, 175 (1984), https://www.ftc.gov/legal-library/ 

browse/ftc-policy-statement-deception, appended to 

In Re Cliffdale Assocs., Inc., 103 F.T.C. 110 (1984) 

(in determining whether a practice is deceptive ‘‘we 

examine the practice from the perspective of a 

consumer acting reasonably’’). 

authentic reviews from customers who 

had received and had a chance to use 

the products, the complaint charges 

Sitejabber with deceptive conduct in 

violation of section 5. 

Sitejabber is also accused of having 

provided its retail clients with widgets 

by which the retailers could embed the 

IFPR-derived product ratings on their 

own websites. These widgets had no 

purpose other than to represent that 

those product ratings were derived from 

the reviews of consumers who had 

received and had a chance to use the 

product in question. This representation 

was false given that the ratings were 

obtained from consumers who had not 

received the product when they 

provided the rating. For offering this 

widget, the complaint charges Sitejabber 

with a further section 5 violation for 

providing the means and 

instrumentalities for the commission of 

deceptive acts and practices. 

Sitejabber’s condemned business 

practices are very different from Rytr’s. 

Rytr provided an AI-powered writing 

tool which could be used to generate 

draft consumer reviews.5 Although a 

consumer or business could have used 

Rytr’s tool to generate a false product 

review, and that false product review 

could in some circumstances violate 

section 5’s prohibition on deceptive acts 

or practices, that was not necessarily the 

case.6 Indeed, the Commission did not 

supply a single example of someone 

having used Rytr’s tool to violate section 

5.7 A consumer also could have used 

Rytr’s tool to generate an initial draft of 

a perfectly honest consumer review.8

The mere fact that someone could use 

a product to commit fraud does not 

make that product the means and 

instrumentalities to commit fraud.9 In 

my view, the provision of a product or 

service with potential unlawful uses is 

not the provision of the means and 

instrumentalities to violate section 5 

unless (1) the instrumentality in 

question ‘‘has no or de minimis legal 

use’’; 10 (2) the provider of the 

instrumentality had the purpose of 

facilitating the section 5 violation; 11 or 

(3) the provider ‘‘knows, or has reason 

to know, that the person to whom the 

product or service was supplied will use 

it to violate section 5.’’ 12

Whereas Rytr’s review generator tool 

satisfied none of those requirements, the 

allegations in the complaint here show 

that Sitejabber’s product satisfies all 

three. First, there is no legitimate 

purpose for a widget displaying an 

instant product review rating. No 

reasonable consumer would be 

interested in a one-to-five-star product 

rating derived from reviews left by other 

consumers who had not yet received or 

used the product.13 When a consumer 

views a product rating, he reasonably 

assumes that the rating is based on 

reviewers’ experiences with the 

product, not with the purchasing 

process. Second, because the widgets 

had no use other than to deceive 

consumers, we can reasonably infer that 

Sitejabber knew that every single one of 

its clients was using them for that 

purpose. Finally, there is ample 

evidence that Sitejabber’s very purpose 

in offering the widgets was to assist in 

the deception of consumers. The 

widgets were nothing but an extension 

of the same deception that Sitejabber 

was carrying out on its own website 

using the same deceptive ratings and on 

behalf of the same clients. 

I therefore concur in the 

Commission’s complaint and proposed 

consent order against Sitejabber. 

[FR Doc. 2024–26711 Filed 11–15–24; 8:45 am] 

BILLING CODE 6750–01–P 

UNITED STATES AGENCY FOR 

GLOBAL MEDIA 

Performance Review Board Members 

AGENCY: United States Agency for 

Global Media. 

ACTION: Notice. 

SUMMARY: The United States Agency for 

Global Media (USAGM) announces the 

members of its SES Performance Review 

Board (PRB). 

ADDRESSES: USAGM Office of Human 

Resources, 330 Independence Ave. SW, 

Washington, DC 20237. 

FOR FURTHER INFORMATION CONTACT: 

Ellona Fritschie, Senior Advisor, at 

efritschie@usagm.gov or (202) 920–2400. 

SUPPLEMENTARY INFORMATION: In 

accordance with 5 U.S.C. 4314, USAGM 

publishes this notice announcing the 

individuals who will serve as members 

of the PRB for a term of one year. The 

PRB is responsible for: (1) reviewing 

performance appraisals and ratings of 

Senior Executive Service and Senior 

Level members; and (2) making 

recommendations on other performance 

management issues, such as pay 

adjustments, bonuses, and Presidential 

Rank Awards. The names, position 

titles, and appointment types of each 

member of the PRB are set forth below: 

1. Grant Turner, Chief Risk Officer, 

Career SES 

2. David Kotz, Chief Management 

Officer, Career SES 

3. Sylvia Rosabal, Director, Office of 

Cuban Broadcasting, Non-Career SES 

4. Adrienne Fleming, Deputy Director, 

TSI, Career SES 

Dated: November 13, 2024. 

Armanda Matthews, 

Program Support Specialist, U.S. Agency for 

Global Media. 

[FR Doc. 2024–26849 Filed 11–15–24; 8:45 am] 

BILLING CODE 8610–01–P 

GULF COAST ECOSYSTEM 

RESTORATION COUNCIL 

[Docket No.: 111132024–1111–05] 

Senior Executive Service Performance 

Review Board Membership 

AGENCY: Gulf Coast Ecosystem 

Restoration Council (GCERC). 

ACTION: Notice of Performance Review 

Board (PRB) appointments. 

SUMMARY: This notice announces the 

members of the Senior Executive 

Service (SES) Performance Review 

Board. The PRB is comprised of a 

Chairperson and a mix of state 

representatives and career senior 

executives that meet annually to review 

and evaluate performance appraisal 

documents and provide a written 

recommendation to the Chairperson of 

the Council for final approval of each 

executive’s performance rating, 

performance-based pay adjustment, and 

performance award. 

DATES: The board membership is 

applicable beginning on January 1, 2024 

and ending on December 31, 2024. 

FOR FURTHER INFORMATION CONTACT: 

Mary S. Walker, Executive Director, 

Gulf Coast Ecosystem Restoration 

Council, telephone 504–210–9982. 

SUPPLEMENTARY INFORMATION: In 

accordance with 5 U.S.C. 4314(c)(4), the 

persons named below have been 

selected to serve on the PRB: 

Gulf Coast Ecosystem Restoration 

Council 

Walker, Mary S., Executive Director, 

Mary.Walker@restorethegulf.gov, 504– 

210–9982 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 89, No. 222 / Monday, November 18, 2024 / Notices 90695 

Department of Interior 

Blanchard, Mary Josie, Deputy Director, 

Environmental Protection 

Compliance, MaryJosie_Blanchard@

ios.doi.gov, 202–208–3406 

State of Florida 

Blalock, Adam, Deputy Secretary for 

Ecosystem Restoration, 

Adam.Blalock@floridadep.gov, 850– 

245–2118 

State of Alabama 

Blankenship, Chris, Commissioner, 

Alabama Department of Conservation 

and Natural Resources, 

Chris.blankenship@dcnr.alabama.gov, 

334–242–3486 

Environmental Protection Agency 

Wyatt, Marc, Director, Gulf of Mexico 

Division, Wyatt.marc@epa.gov, 228– 

679–5915 

Keala J. Hughes, 

Director of External Affairs & Tribal Relations, 

Gulf Coast Ecosystem Restoration Council. 

[FR Doc. 2024–26818 Filed 11–15–24; 8:45 am] 

BILLING CODE 6560–58–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Supplemental Evidence and Data 

Request on Dietary Total Fat Intake 

and Dietary Polyunsaturated Fatty Acid 

Intake and Child Growth and 

Development Outcomes: A Systematic 

Review 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Request for supplemental 

evidence and data submission. 

SUMMARY: The Agency for Healthcare 

Research and Quality (AHRQ) is seeking 

scientific information submissions from 

the public. Scientific information is 

being solicited to inform our review on 

Dietary Total Fat Intake and Dietary 

Polyunsaturated Fatty Acid Intake and 

Child Growth and Development 

Outcomes: A Systematic Review, which 

is currently being conducted by the 

AHRQ’s Evidence-based Practice 

Centers (EPC) Program. Access to 

published and unpublished pertinent 

scientific information will improve the 

quality of this review. 

DATES: Submission Deadline on or 

before December 18, 2024. 

ADDRESSES: 

Email submissions: epc@

ahrq.hhs.gov. 

Print submissions: 

Mailing Address: Center for Evidence 

and Practice Improvement, Agency for 

Healthcare Research and Quality, 

ATTN: EPC SEADs Coordinator, 5600 

Fishers Lane, Mail Stop 06E53A, 

Rockville, MD 20857. 

Shipping Address (FedEx, UPS, etc.): 

Center for Evidence and Practice 

Improvement, Agency for Healthcare 

Research and Quality, ATTN: EPC 

SEADs Coordinator, 5600 Fishers Lane, 

Mail Stop 06E77D, Rockville, MD 

20857. 

FOR FURTHER INFORMATION CONTACT: 

Kelly Carper, Telephone: 301–427–1656 

or Email: epc@ahrq.hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

Agency for Healthcare Research and 

Quality has commissioned the 

Evidence-based Practice Centers (EPC) 

Program to complete a review of the 

evidence for Dietary Total Fat Intake 

and Dietary Polyunsaturated Fatty Acid 

Intake and Child Growth and 

Development Outcomes: A Systematic 

Review. AHRQ is conducting this 

review pursuant to Section 902 of the 

Public Health Service Act, 42 U.S.C. 

299a. 

The EPC Program is dedicated to 

identifying as many studies as possible 

that are relevant to the questions for 

each of its reviews. In order to do so, we 

are supplementing the usual manual 

and electronic database searches of the 

literature by requesting information 

from the public (e.g., details of studies 

conducted). We are looking for studies 

that report on Dietary Total Fat Intake 

and Dietary Polyunsaturated Fatty Acid 

Intake and Child Growth and 

Development Outcomes: A Systematic 

Review. The entire research protocol is 

available online at: https://

effectivehealthcare.ahrq.gov/products/ 

child-growth-development-outcomes/ 

protocol. 

This is to notify the public that the 

EPC Program would find the following 

information on Dietary Total Fat Intake 

and Dietary Polyunsaturated Fatty Acid 

Intake and Child Growth and 

Development Outcomes: A Systematic 

Review helpful: 

D A list of completed studies that 

your organization has sponsored for this 

topic. In the list, please indicate 

whether results are available on 

ClinicalTrials.gov along with the 

ClinicalTrials.gov trial number. 

D For completed studies that do not 

have results on ClinicalTrials.gov, a 

summary, including the following 

elements, if relevant: study number, 

study period, design, methodology, 

indication and diagnosis, proper use 

instructions, inclusion and exclusion 

criteria, primary and secondary 

outcomes, baseline characteristics, 

number of patients screened/eligible/ 

enrolled/lost to follow-up/withdrawn/ 

analyzed, effectiveness/efficacy, and 

safety results. 

D A list of ongoing studies that your 

organization has sponsored for this 

topic. In the list, please provide the 

ClinicalTrials.gov trial number or, if the 

trial is not registered, the protocol for 

the study including, if relevant, a study 

number, the study period, design, 

methodology, indication and diagnosis, 

proper use instructions, inclusion and 

exclusion criteria, and primary and 

secondary outcomes. 

D Description of whether the above 

studies constitute ALL Phase II and 

above clinical trials sponsored by your 

organization for this topic and an index 

outlining the relevant information in 

each submitted file. 

Your contribution is very beneficial to 

the Program. Materials submitted must 

be publicly available or able to be made 

public. Materials that are considered 

confidential; marketing materials; study 

types not included in the review; or 

information on topics not included in 

the review cannot be used by the EPC 

Program. This is a voluntary request for 

information, and all costs for complying 

with this request must be borne by the 

submitter. 

The draft of this review will be posted 

on AHRQ’s EPC Program website and 

available for public comment for a 

period of 4 weeks. If you would like to 

be notified when the draft is posted, 

please sign up for the email list at: 

https://effectivehealthcare.ahrq.gov/ 

email-updates. 

The review will answer the following 

questions. This information is provided 

as background. AHRQ is not requesting 

that the public provide answers to these 

questions. 

Key Questions (KQ) 

KQ 1: What is the association between 

dietary intake of omega-6 and/or omega3 polyunsaturated fatty acids during 

pregnancy and risk of preterm birth? 

KQ 1a: How are these associations 

affected by intervention/exposure 

characteristics (for example, the ratio of 

different fatty acids)? 

KQ 2: What is the association between 

dietary intake of omega-6 and/or omega3 polyunsaturated fatty acids during 

pregnancy and/or lactation and infant/ 

child growth and developmental 

outcomes? 

KQ 2a: How are these associations 

affected by intervention/exposure 

characteristics (for example, the ratio of 

different fatty acids)? 


lotter on DSK11XQN23PROD with NOTICES1